Eric Sacks - 23 Jul 2025 Form 4 Insider Report for Coatue Innovative Strategies Fund

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
25 Jul 2025, 17:10:22 UTC
Prior SEC filing
30 Apr 2025
Next SEC filing
20 Oct 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Claire Jen, as Attorney-in-fact
Filing notes and source

Key filing fact

Eric Sacks filed Form 4 for Coatue Innovative Strategies Fund on 25 Jul 2025.

Key facts

  • This page summarizes Eric Sacks's Form 4 filing for Coatue Innovative Strategies Fund.
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 25 Jul 2025, 17:10.

Change

  • Previous filing in this sequence was filed on 30 Apr 2025.
  • Current net transaction value: +$500,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002062306 Primary reporting owner

Sacks Eric

Relationship
Chief Financial Officer
Address
C/O COATUE MANAGEMENT, L.L.C., 9 WEST 57TH STREET, 25TH FLOOR, NEW YORK
Signature
/s/ Claire Jen, as Attorney-in-fact
Signature date
25 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

No ticker transaction

Class I Shares

Award

Transaction value
$500,000
Shares
+47,527
Change %
Price
$10.52
Shares after
47,527
Date
23 Jul 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On July 23, 2025, the Issuer determined the purchase price per Class I share and fixed the number of Class I shares acquired in respect of the Reporting Person's prior subscription.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .